Pharma News India

The US based company operated in the area of sterile injectable capacity.

New Delhi, July 16, 2014: The Indian drug firm Sun Pharmaceuticals has acquired Pharmalucence Inc. The US-based company is into sterile injectable capacity and has been acquired by one of the subsidiaries of Sun Pharma.

The investments will be made as part of the expansion plan of Cipla in the UK.

New Delhi, July 8, 2014: Cipla plans to invest up to 100 million pounds in UK over the next few years for launch and development of new drugs as part of its global footprint expansion plans. The company plans to provide high quality affordable medicines to British National Health Service (NHS).

The R&D centres would focus on research in inhalation and complex formulations.

Mumbai, July 6, 2014: The Indian pharma firm Lupin is planning to set up two new R&D centres in the US focusing on research in inhalation and complex formulations.

Top pharma companies from US favour dialogue with India on IP rights and clinical trials.

New Delhi, June 30, 2014: Top management executives from the US based pharmaceutical firms favour dialogue with Indian to address their concerns on key issues like protection of intellectual property (IP) rights and clinical trials. This development came to fore at the recently held "US-India...

The drug will be made from commonly used Indian spices.

New Delhi, June 25, 2014: A recently done study has found out that commonly used Indian spices in soups, curries and rasam, when used in a specific proportion with white lotus petals, can bring down blood pressure.



* Indicates mandatory field.
Please wait while comments are being sent...